Table 1.
Characteristics of the participants
| Variables | n (%) |
Knowledge
|
Attitude
|
Practice
|
|||
|
mean ± SD
|
P value
|
mean ± SD
|
P value
|
mean ± SD
|
P value
|
||
| Total | 353 | 10.05 ± 3.46 | 41.58 ± 5.23 | 44.20 ± 7.39 | |||
| Gender | 0.468 | 0.830 | 0.077 | ||||
| Male | 224 (63.5) | 9.95 ± 3.57 | 41.62 ± 5.02 | 44.72 ± 7.35 | |||
| Female | 129 (36.5) | 10.2 ± 3.28 | 41.50 ± 5.59 | 43.28 ± 7.40 | |||
| Age, yr (10 cases missing) | < 0.001 | 0.142 | 0.886 | ||||
| ≤ 20 | 41 (11.6) | 9.46 ± 3.87 | 40.95 ± 5.13 | 44.00 ± 8.15 | |||
| 20-30 | 116 (32.9) | 10.87 ± 2.94 | 42.41 ± 5.25 | 44.37 ± 7.40 | |||
| 30-40 | 85 (24.1) | 10.56 ± 3.03 | 41.81 ± 5.24 | 43.89 ± 6.92 | |||
| > 40 | 101 (28.6) | 9.02 ± 3.91 | 40.88 ± 5.21 | 44.70 ± 7.27 | |||
| Ethnicity (1 case missing) | 0.011 | 0.028 | 0.609 | ||||
| Han | 341 (96.6) | 10.13 ± 3.39 | 41.69 ± 5.16 | 44.25 ± 7.41 | |||
| Minorities | 11 (3.1) | 7.45 ± 4.89 | 38.18 ± 6.51 | 43.09 ± 6.85 | |||
| Residence | 0.006 | 0.059 | 0.002 | ||||
| Rural | 149 (42.2) | 9.38 ± 3.72 | 44.18 ± 5.19 | 43.76 ± 7.76 | |||
| City | 122 (34.6) | 10.66 ± 3.05 | 42.48 ± 5.05 | 45.97 ± 6.73 | |||
| Suburb/urban-rural combination | 82 (23.2) | 10.35 ± 3.85 | 40.95 ± 5.45 | 42.35 ± 7.13 | |||
| Education | < 0.001 | 0.003 | 0.089 | ||||
| Primary school and below | 25 (7.1) | 6.92 ± 3.53 | 40.00 ± 4.97 | 42.88 ± 7.21 | |||
| Middle school | 67 (19.0) | 7.99 ± 4.17 | 39.99 ± 5.82 | 42.40 ± 8.01 | |||
| High school/technical secondary school | 84 (23.8) | 10.25 ± 2.88 | 41.42 ± 4.83 | 44.55 ± 6.98 | |||
| Junior college/bachelor’s degree and above | 177 (50.1) | 11.18 ± 2.75 | 42.47 ± 5.05 | 44.89 ± 7.29 | |||
| Work status | < 0.001 | 0.002 | 0.012 | ||||
| Employed | 185 (52.4) | 10.79 ± 2.96 | 42.39 ± 4.90 | 45.13 ± 6.83 | |||
| Other | 168 (47.6) | 9.23 ± 3.78 | 40.68 ± 5.44 | 43.17 ± 7.85 | |||
| Monthly per capita income | < 0.001 | 0.003 | 0.074 | ||||
| < 5000 | 173 (49.0) | 9.32 ± 3.87 | 40.61 ± 5.20 | 43.29 ± 7.95 | |||
| 5000-10000 | 104 (29.5) | 10.88 ± 2.52 | 42.37 ± 4.96 | 45.21 ± 6.59 | |||
| > 10000 | 76 (21.5) | 10.55 ± 3.27 | 42.68 ± 5.32 | 44.87 ± 6.93 | |||
| Marital status | 0.029 | 0.939 | 0.201 | ||||
| Unmarried or other | 157 (44.5) | 10.50 ± 3.21 | 41.60 ± 5.25 | 44.76 ± 7.40 | |||
| Married | 196 (55.5) | 9.69 ± 3.62 | 41.56 ± 5.23 | 43.74 ± 7.37 | |||
| Smoking habit | 0.163 | 0.386 | 0.202 | ||||
| No (no smoking) | 282 (79.9) | 10.18 ± 3.33 | 41.45 ± 5.13 | 43.94 ± 7.18 | |||
| Yes (smoking or used to smoke) | 71 (20.1) | 9.54 ± 3.92 | 42.06 ± 5.63 | 45.20 ± 8.14 | |||
| Drinking habit | 0.461 | 0.744 | 0.372 | ||||
| No (no drinking) | 240 (68.0) | 10.14 ± 3.40 | 41.51 ± 5.27 | 43.95 ± 7.36 | |||
| Yes (drinking or used to drink) | 113 (32.0) | 9.85 ± 3.59 | 41.71 ± 5.16 | 44.71 ± 7.47 | |||
| Medical insurance type (multiple choices) | |||||||
| Basic medical insurance for urban employees | 187 (53.0) | 10.68 ± 3.06 | < 0.001 | 43.62 ± 4.98 | < 0.001 | 44.79 ± 7.14 | 0.108 |
| New cooperative medical insurance | 112 (31.7) | 9.16 ± 4.02 | 0.001 | 54.18 ± 5.45 | 0.001 | 43.34 ± 7.88 | 0.138 |
| Basic medical insurance for urban residents | 62 (17.6) | 9.18 ± 3.77 | 0.029 | 55.13 ± 4.87 | 0.460 | 44.56 ± 6.71 | 0.666 |
| Commercial insurance | 23 (6.5) | 10.74 ± 3.37 | 0.323 | 56.30 ± 4.76 | 0.490 | 45.61 ± 7.24 | 0.343 |
| No insurance | 3 (0.8) | 12.33 ± 1.15 | 0.252 | 52.00 ± 4.58 | 0.235 | 34.67 ± 9.29 | 0.025 |
| Which IBD | < 0.001 | 0.005 | 0.553 | ||||
| Ulcerative colitis | 133 (37.7) | 9.16 ± 3.69 | 54.57 ± 5.06 | 43.89 ± 7.55 | |||
| Crohn’s disease | 220 (62.3) | 10.59 ± 3.21 | 56.18 ± 5.25 | 44.38 ± 7.30 | |||
| Duration of IBD | 0.995 | 0.948 | 0.248 | ||||
| < 1 yr | 239 (67.7) | 10.05 ± 3.46 | 55.58 ± 5.17 | 44.65 ± 7.36 | |||
| 1-2 yr | 59 (16.7) | 10.08 ± 3.43 | 55.41 ± 5.30 | 43.17 ± 7.72 | |||
| > 2 yr | 55 (15.6) | 10.02 ± 3.56 | 55.73 ± 5.59 | 43.33 ± 7.09 | |||
| Ostomy | 0.014 | 0.088 | 0.621 | ||||
| Yes | 27 (7.6) | 8.48 ± 4.37 | 53.93 ± 5.95 | 43.52 ± 10.05 | |||
| No | 326 (92.4) | 10.18 ± 3.53 | 55.71 ± 5.15 | 44.25 ± 7.14 | |||
| Comorbidities | 0.463 | 0.064 | 0.004 | ||||
| Yes | 59 (16.7) | 9.75 ± 3.72 | 54.42 ± 5.11 | 41.71 ± 7.32 | |||
| No | 294 (83.3) | 10.11 ± 3.41 | 55.81 ± 5.23 | 44.64 ± 7.28 | |||
| Family history of IBD | 0.588 | 0.991 | 0.392 | ||||
| Yes | 9 (2.5) | 10.67 ± 4.21 | 55.56 ± 4.98 | 42.11 ± 6.43 | |||
| No | 344 (97.5) | 10.03 ± 3.45 | 55.58 ± 5.24 | 44.25 ± 7.41 | |||
| Surgical history | 0.340 | 0.487 | 0.894 | ||||
| Yes | 165 (46.7) | 10.24 ± 3.39 | 55.78 ± 5.10 | 44.14 ± 7.47 | |||
| No | 188 (53.3) | 9.88 ± 3.53 | 55.39 ± 5.35 | 44.24 ± 7.34 | |||
| History of drug allergy | 0.110 | 0.120 | 0.890 | ||||
| Yes | 48 (13.6) | 10.79 ± 2.73 | 56.67 ± 5.15 | 44.33 ± 7.36 | |||
| No | 305 (86.4) | 9.93 ± 3.55 | 55.40 ± 5.23 | 44.17 ± 7.41 | |||
| What kind of treatment is being received? | 0.040 | 0.004 | 0.276 | ||||
| 5-aminosalicylic acid drugs (e.g., mesalazine) | 19 (5.4) | 8.63 ± 3.44 | 55.00 ± 4.99 | 45.32 ± 8.87 | |||
| Glucocorticoids | 1 (0.3) | 12.00 | 57.00 | 50.00 | |||
| Immunosuppressants (e.g., azathioprine, tacrolimus, cyclosporine, etc.) | 6 (1.7) | 6.50 ± 3.27 | 51.33 ± 6.38 | 37.83 ± 9.99 | |||
| Biological agents (e.g., infliximab, vedolizumab, ustekinumab) | 301 (85.3) | 10.16 ± 3.49 | 55.97 ± 5.13 | 44.33 ± 7.26 | |||
| Biological agents + immunosuppressants | 14 (4.0) | 9.93 ± 3.34 | 51.36 ± 5.58 | 43.57 ± 6.73 | |||
| Biological agents + 5-aminosalicylic acid drugs | 12 (3.4) | 11.25 ± 1.48 | 53.42 ± 4.36 | 42.50 ± 6.99 | |||
IBD: Inflammatory bowel disease.